Hepatitis C Infection May Increase Cardiovascular Risk
By LabMedica International staff writers Posted on 30 Aug 2015 |
Image: Scanning electron micrograph of Hepatitis C viruses (Photo courtesy of Cardiff University).
People infected with the Hepatitis C virus (HCV) are at risk for liver damage, but the infection may also lead to cardiovascular damage.
A recent study found that participants chronically infected with hepatitis C were more likely to harbor abnormal fat-and-calcium plaques inside their arteries, a condition known as atherosclerosis and a common forerunner of heart attacks and strokes.
Scientists at the Johns Hopkins Bloomberg School of Public Health (Baltimore, MD, USA) and their colleagues assessed 994 men 40 to 70 years old without overt heart disease who were followed across several institutions in Baltimore, Washington DC, Pittsburgh, Los Angeles, and Chicago. Of the 994, 613 were infected with human immunodeficiency virus (HIV), 70 were infected with both viruses and 17 were only infected with hepatitis C. Participants underwent cardiac computed tomography (CT) scans to detect and measure the amount of fat and calcium deposits inside the vessels of their hearts.
Study participants who had higher levels of circulating HCV in their blood were 50% more likely to have clogged arteries, compared with men without hepatitis C. Higher virus levels in the blood signal that the infection is not well controlled by drugs or the immune system. Poorly controlled infection, the investigators added, may lead to more inflammation throughout the body, which can fuel blood vessel damage and thus contribute to heart disease. Those infected with hepatitis C, regardless of HIV status, had, on average, 30% more disease-fueling calcified plaque in their arteries, the main driver of heart attack and stroke risk. People infected with either HIV or hepatitis C, on average, had 42% more non-calcified fatty buildup, a type of plaque believed to confer the greatest cardiac risk.
Eric Seaberg, PhD, assistant professor of epidemiology, and lead investigator, said, “We have strong reason to believe that infection with hepatitis C fuels cardiovascular disease, independent of HIV and sets the stage for subsequent cardiovascular trouble. We believe our findings are relevant to anyone infected with hepatitis C regardless of HIV status.” The authors concluded that chronic HCV infection is associated with subclinical cardiovascular disease, suggesting that HCV-infected individuals warrant vigilant cardiovascular risk assessments. The study was published on July 27, 2015, in the Journal of Infectious Diseases.
Related Links:
Johns Hopkins Bloomberg School of Public Health
A recent study found that participants chronically infected with hepatitis C were more likely to harbor abnormal fat-and-calcium plaques inside their arteries, a condition known as atherosclerosis and a common forerunner of heart attacks and strokes.
Scientists at the Johns Hopkins Bloomberg School of Public Health (Baltimore, MD, USA) and their colleagues assessed 994 men 40 to 70 years old without overt heart disease who were followed across several institutions in Baltimore, Washington DC, Pittsburgh, Los Angeles, and Chicago. Of the 994, 613 were infected with human immunodeficiency virus (HIV), 70 were infected with both viruses and 17 were only infected with hepatitis C. Participants underwent cardiac computed tomography (CT) scans to detect and measure the amount of fat and calcium deposits inside the vessels of their hearts.
Study participants who had higher levels of circulating HCV in their blood were 50% more likely to have clogged arteries, compared with men without hepatitis C. Higher virus levels in the blood signal that the infection is not well controlled by drugs or the immune system. Poorly controlled infection, the investigators added, may lead to more inflammation throughout the body, which can fuel blood vessel damage and thus contribute to heart disease. Those infected with hepatitis C, regardless of HIV status, had, on average, 30% more disease-fueling calcified plaque in their arteries, the main driver of heart attack and stroke risk. People infected with either HIV or hepatitis C, on average, had 42% more non-calcified fatty buildup, a type of plaque believed to confer the greatest cardiac risk.
Eric Seaberg, PhD, assistant professor of epidemiology, and lead investigator, said, “We have strong reason to believe that infection with hepatitis C fuels cardiovascular disease, independent of HIV and sets the stage for subsequent cardiovascular trouble. We believe our findings are relevant to anyone infected with hepatitis C regardless of HIV status.” The authors concluded that chronic HCV infection is associated with subclinical cardiovascular disease, suggesting that HCV-infected individuals warrant vigilant cardiovascular risk assessments. The study was published on July 27, 2015, in the Journal of Infectious Diseases.
Related Links:
Johns Hopkins Bloomberg School of Public Health
Latest Microbiology News
- Integrated Solution Ushers New Era of Automated Tuberculosis Testing
- Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections
- Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases
- Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle
- New CE-Marked Hepatitis Assays to Help Diagnose Infections Earlier
- 1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens
- Mouth Bacteria Test Could Predict Colon Cancer Progression
- Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
- Groundbreaking Diagnostic Platform Provides AST Results With Unprecedented Speed
- Simple Blood Test Combined With Personalized Risk Model Improves Sepsis Diagnosis
- Blood Analysis Predicts Sepsis and Organ Failure in Children
- TB Blood Test Could Detect Millions of Silent Spreaders
- New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours
- New Tuberculosis Test to Expand Testing Access in Low- and Middle-Income Countries
- Rapid Test Diagnoses Tropical Disease within Hours for Faster Antibiotics Treatment
- Rapid Molecular Testing Enables Faster, More Targeted Antibiotic Treatment for Pneumonia